more >
trade ideas
trade ideas
HOME
trade ideas
AI TRADING
investing
INVESTING
CREATE & TRACK
DISCOVER & FOLLOW
screener
SCREENER
marketplace
MARKETPLACE
MARKETPLACE
COMMUNITY
academy
ACADEMY
Pricing
Loading...
Find your wayMarket SummaryDashboardWhat`s new AI Robots1-on-1 lessonsHelpSale
MENU
BCEL
AS OF
Mar 18 closing price
Price
$0.15
Change
-$0.00 (-0.00%)
Capitalization
3.65M
78 days until earnings call
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
© 2013-2024 All rights reserved. Tickeron Inc.

BCEL Stock BCEL is expected to report earnings to fall -20% to -26 cents per share on May 20

GET DAILY SIGNALS
A.I.dvisor
at Tickeron.com
05/19/24
Loading...
BCEL - Atreca, Inc.
Atreca, Inc. Earnings Graph
Q1'24
Est.
$-0.26
Q4'23
Beat
by $0.13
Q3'23
Missed
by $0.54
Q2'23
Beat
by $0.08
Q1'23
Beat
by $0.03
The last earnings report on December 31 showed earnings per share of -22 cents, beating the estimate of -35 cents. P/B Ratio (0.339) is normal, around the industry mean (12.558). P/E Ratio (0.000) is within average values for comparable stocks, (151.642). BCEL's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.434). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (241.835). With 36.80K shares outstanding, the current market capitalization sits at 3.65M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
835 Industrial Road
Phone
+1 650 595-2595
Employees
90
Web
https://www.atreca.com